Download the Document | |
Published on | 09 March 2018 |
Debated in | 1st Reading | 2nd Reading | Committee | Recommittal | 3rd Reading |
---|---|---|---|---|---|
Sitting No. 057
-
27 Nov 2017
Plenary Session |
⦿ | ||||
Sitting No. 063
-
11 Dec 2017
Plenary Session |
⦿ | ||||
Sitting No. 068
-
15 Jan 2018
Plenary Session |
⦿ | ||||
Sitting No. 069
-
16 Jan 2018
Plenary Session |
⦿ | ||||
Sitting No. 078
-
05 Feb 2018
Plenary Session |
⦿ | ||||
Sitting No. 015
-
01 Mar 2018
Consideration of Bills Committee |
⦿ | ||||
Sitting No. 090
-
06 Mar 2018
Plenary Session |
⦿ |
The object and reasons of this Bill are to widen the scope of article 10 of the Drug Dependence (Treatment not Imprisonment) Act so as to allow prescription of Synthetic cannabinoids, cannabis products produced under Good Manufacturing Practice and to allow prescribing by all licenced medical practitioners who are duly registered in accordance with the Health Care Professions Act.